16
Participants
Start Date
September 16, 2025
Primary Completion Date
December 16, 2026
Study Completion Date
December 16, 2026
Breast milk, plasma, and blood samples
Although this study is non- interventional regarding treatment with ozanimod, the study is considered interventional due to the collection of breast milk and plasma from the lactating women and blood samples from their breastfed infants and the additional diagnostic and monitoring procedures required for the study.
RECRUITING
PPD Las Vegas Clinical Research Unit, Las Vegas
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY